Updated
Updated · Fox News · Jul 9
CMS Launches $50 Medicare GLP-1 Bridge Program as Oz Backs Weight-Loss Drugs
Updated
Updated · Fox News · Jul 9

CMS Launches $50 Medicare GLP-1 Bridge Program as Oz Backs Weight-Loss Drugs

3 articles · Updated · Fox News · Jul 9

Summary

  • $50 a month is the price point for CMS's new Medicare GLP-1 Bridge program, which Dr. Mehmet Oz said will expand seniors' access to weight-loss drugs if they meet health criteria and get prior authorization.
  • Oz said he supports GLP-1s when used correctly with diet, exercise and medical supervision, arguing they can help overweight patients who struggle with mobility, hypertension or diabetes.
  • CMS is framing the push as a cost-saving move, with Oz saying obesity is the top driver of chronic disease and that roughly 70% of healthcare spending stems from chronic conditions.
  • The program also targets overweight people who lack the conditions typically required for Medicare coverage, signaling a broader federal embrace of GLP-1 treatment while stopping short of calling the drugs a standalone fix.

Insights

With Medicare's GLP-1 program ending in 2027, what is the long-term plan for patients to maintain their weight loss?
As GLP-1s become mainstream, are we creating drug dependency instead of fixing the root causes of the obesity epidemic?
Will subsidizing weight-loss drugs save taxpayer money, or is it a costly gamble on America's long-term health habits?